OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic reprogramming in cancer: From diagnosis to treatment
Pedro M. S. Costa, Sarah Leyenne Alves Sales, Daniel Pascoalino Pinheiro, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

c-FLIP/Ku70 complex; A potential molecular target for apoptosis induction in hepatocellular carcinoma
Yasamin Haghir-Sharif-Zamini, Arezoo Khosravi, Moustapha Hassan, et al.
Archives of Biochemistry and Biophysics (2025), pp. 110306-110306
Closed Access

Post-Translational Modifications of Proteins Orchestrate All Hallmarks of Cancer
Pathea Bruno, Aneeta Arshad, Maria-Raluca Gogu, et al.
Life (2025) Vol. 15, Iss. 1, pp. 126-126
Open Access

Potential prognostic and predictive biomarkers: METTL5, METTL7A, and METTL7B expression in gastrointestinal cancers
Shirin Heydari, Maryam Peymani, Mehrdad Hashemi, et al.
Molecular Biology Reports (2025) Vol. 52, Iss. 1
Closed Access

Chemical catalyst manipulating cancer epigenome and transcription
Yuki Yamanashi, Shinpei Takamaru, Atsushi Okabe, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access

Cellular Epigenetic Targets and Epidrugs in Breast Cancer Therapy: Mechanisms, Challenges, and Future Perspectives
Ibrahim S. Alalhareth, Saleh M. Alyami, Abdulrhman Alshareef, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 207-207
Open Access

Epigenomic Echoes—Decoding Genomic and Epigenetic Instability to Distinguish Lung Cancer Types and Predict Relapse
Anke Baumann, Zholdas Buribayev, Olaf Wolkenhauer, et al.
Epigenomes (2025) Vol. 9, Iss. 1, pp. 5-5
Open Access

Deregulated transcription factors in the emerging cancer hallmarks
Adria Hasan, Naushad Ahmad Khan, Shahab Uddin, et al.
Seminars in Cancer Biology (2023) Vol. 98, pp. 31-50
Closed Access | Times Cited: 10

Associations of Heavy Metals with Cognitive Function: An Epigenome‐Wide View of DNA Methylation and Mediation Analysis
Yue Wei, Yanfeng Zhou, Lili Xiao, et al.
Annals of Neurology (2024) Vol. 96, Iss. 1, pp. 87-98
Closed Access | Times Cited: 2

Advances in Hodgkin Lymphoma Treatment: From Molecular Biology to Clinical Practice
C. Savelli, Matteo Bisio, Luca Legato, et al.
Cancers (2024) Vol. 16, Iss. 10, pp. 1830-1830
Open Access | Times Cited: 1

Chemical catalyst manipulating cancer epigenome and transcription
Yuki Yamanashi, Shinpei Takamaru, Atsushi Okabe, et al.
(2024)
Open Access | Times Cited: 1

Chemical catalyst manipulating cancer epigenome and transcription
Yuki Yamanashi, Shinpei Takamaru, Atsushi Okabe, et al.
(2024)
Open Access | Times Cited: 1

Research Progress on the Role of Epigenetic Methylation Modification in Hepatocellular Carcinoma
J Wang, Wenyue Gao, Hongbo Yu, et al.
Journal of Hepatocellular Carcinoma (2024) Vol. Volume 11, pp. 1143-1156
Open Access | Times Cited: 1

The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors
Penghui Li, Xiao Ma, Xinyu Gu
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 1

The bidirectional interplay between ncRNAs and methylation modifications in gastrointestinal tumors
Minyu Kong, Yu Xiao, Wenzhi Guo, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 15, pp. 4834-4848
Open Access | Times Cited: 4

Decitabine/paclitaxel co-delivery systems modified with anti-PD-L1 antibodies mediate chemoimmunotherapy for Triple negative breast cancer
Yang He, Qin Hu, Liting Wang, et al.
Materials & Design (2023) Vol. 237, pp. 112562-112562
Open Access | Times Cited: 2

Clinical Experiences with Immune Checkpoint Inhibitors in Lymphomas
John M. Timmerman
(2024), pp. 190-207
Closed Access

Overview of cancer: Mechanisms of carcinogenesis
Uttara Saran, Chitra Thakur
Elsevier eBooks (2024), pp. 3-34
Closed Access

Novel Co(II), Cu(II) and Zn(II) complexes derived from thiazole containing Schiff base ligands: Green synthesis, antimicrobial and anti-cancer studies
Dnyandev Bhosale, Snehal Nimal, Rajesh N. Gacche, et al.
Inorganic Chemistry Communications (2024), pp. 113320-113320
Closed Access

The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy
Urszula Oleksiewicz, Monika Kuciak, Anna Jaworska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11466-11466
Open Access

Page 1 - Next Page

Scroll to top